CB vs CTKB · P/E 14, rev $59.40B vs rev $200.5M
Chubb Ltd (CB) versus Cytek Biosciences Inc (CTKB) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported CTKB revenue for 2024-12-31 was $200.5M. Net income was -$6.0M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. CTKB currently screens at market cap $421.8M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. CTKB currently screens at market cap $421.8M.
Not investment advice. Open the CB and CTKB stock pages for the full models.
Not investment advice.